Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

The impact of hormone replacement therapy on quality of life and willingness to pay.

Zethraeus N, Johannesson M, Henriksson P, Strand RT.

Br J Obstet Gynaecol. 1997 Oct;104(10):1191-5.

PMID:
9332999
2.

Measuring the impact of menopausal symptoms on quality of life.

Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M.

BMJ. 1993 Oct 2;307(6908):836-40.

3.

Willingness to pay for hormone replacement therapy.

Zethraeus N.

Health Econ. 1998 Feb;7(1):31-8.

PMID:
9541082
4.

Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.

Whittington R, Faulds D.

Pharmacoeconomics. 1994 May;5(5):419-45. Review. Erratum in: Pharmacoeconomics 1995 Sep;8(3):244.

PMID:
10147233
5.

Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema.

Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M.

Br J Dermatol. 1999 Dec;141(6):1067-75.

PMID:
10606854
6.
7.

A cost-effectiveness analysis of hormone replacement therapy in the menopause.

Cheung AP, Wren BG.

Med J Aust. 1992 Mar 2;156(5):312-6.

PMID:
1588862
8.

Determinants of willingness to pay for a new therapy in a sample of menopausal-aged women.

Rasch A, Hodek JM, Runge C, Greiner W.

Pharmacoeconomics. 2009;27(8):693-704. doi: 10.2165/11312740-000000000-00000.

PMID:
19712011
9.

Menopausal symptoms and knowledge towards daily life and hormone replacement therapy among menopausal women in Bangkok.

Chaopotong P, Titapant V, Boriboonhirunsarn D.

J Med Assoc Thai. 2005 Dec;88(12):1768-74.

PMID:
16518972
10.
11.
12.

Are older breast carcinoma survivors willing to take hormone replacement therapy?

Ganz PA, Greendale GA, Kahn B, O'Leary JF, Desmond KA.

Cancer. 1999 Sep 1;86(5):814-20.

PMID:
10463980
13.
14.

Quality of life and hormone therapy in women before and after menopause.

Ekström H, Hovelius B.

Scand J Prim Health Care. 2000 Jun;18(2):115-21.

PMID:
10944068
15.

Decision analysis of hormone replacement therapy after the Women's Health Initiative.

Kim C, Kwok YS.

Am J Obstet Gynecol. 2003 Nov;189(5):1228-33.

PMID:
14634545
16.

[Assessment of quality of life using the Menopause Rating Scale in women aged 40 to 59 years].

Prado Md, Fuenzalida A, Jara D, Figueroa R, Flores D, Blumel JE.

Rev Med Chil. 2008 Dec;136(12):1511-7. doi: /S0034-98872008001200002. Epub 2009 Mar 23. Spanish.

17.

Short-term menopausal hormone therapy for symptom relief: an updated decision model.

Col NF, Weber G, Stiggelbout A, Chuo J, D'Agostino R, Corso P.

Arch Intern Med. 2004 Aug 9-23;164(15):1634-40.

PMID:
15302633
18.

Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma.

Blumenschein K, Johannesson M.

Ann Allergy Asthma Immunol. 1998 Feb;80(2):189-94.

PMID:
9494453
19.

Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures.

Bech P, Munk-Jensen N, Obel EB, Ulrich LG, Eiken P, Nielsen SP.

Psychother Psychosom. 1998 Jul-Oct;67(4-5):259-65.

PMID:
9693354
20.

The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.

Lacroix KA, Bean C, Reilly R, Curran-Celentano J.

Clin Lab Sci. 1997 May-Jun;10(3):145-8.

PMID:
10167774

Supplemental Content

Support Center